Oxidative stress in Alzheimer disease

Gella, Alejandro, Durany, Nuria·2009·Cell Adhesion & Migration

Cited by (482)

Items 101–200 of 482

  1. Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy
    Xiaodi Kou, Lulu Song, Yunhua Wang, Qiao Yu, Hui Ju, Ai‐Hong Yang, Rui Shen · 2019 · Bioorganic & Medicinal Chemistry Letters
  2. Neuropharmacological effects of Nigella sativa.
    Farimah Beheshti, Majid Khazaei, Mahmoud Hosseini · 2016 · PubMed Central
  3. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
    Jose Luis Marco, Óscar M. Bautista‐Aguilera, Gerard Esteban, Mourad Chioua, Katarina M. Nikolic, Danica Agbaba, Ignacio Moraleda, Isabel Iriepa, Elena Soriano, Abdelouahid Samadi et al. · 2014 · Drug Design Development and Therapy
  4. Discovery and LC-MS Characterization of New Crocins in Gardeniae Fructus and Their Neuroprotective Potential
    Yang Ni, Lin Li, Weiyang Zhang, Dan Lu, Caixia Zang, Dan Zhang, Yang Yu, Xin‐Sheng Yao · 2016 · Journal of Agricultural and Food Chemistry
  5. Royal jelly decreases corticosterone levels and improves the brain antioxidant system in restraint and cold stressed rats
    Renata Roland Teixeira, Adriele Vieira de Souza, Leonardo Gomes Peixoto, Hélen Lara Machado, Douglas Carvalho Caixeta, Danielle Diniz Vilela, Nathalia Belele Baptista, Celso Rodrigues Franci, Foued Salmen Espíndola · 2017 · Neuroscience Letters
  6. Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.
    Suzanne M. de la Monte · 2012 · PubMed
  7. Neuroprotective effect of naringin against cerebellar changes in Alzheimer’s disease through modulation of autophagy, oxidative stress and tau expression: An experimental study
    Hend M Hassan, Mohamed R. Elnagar, E.A. Abdel-Razik, Mohamed R. Mahdi, Eman Hamza, Eman M. Elattar, Eman Mohamad El Nashar, Mansour A. Alghamdi, Zainah Al-Qahtani, Khulood Mohammed Al-Khater et al. · 2022 · Frontiers in Neuroanatomy
  8. Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer’s Disease Model
    Nouf Khalifa ALaqeel, Mona Hmoud AlSheikh, Mohammed Taha Al-Hariri · 2022 · Antioxidants
  9. The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms
    Giuseppe Caruso, Lucia Di Pietro, Vincenzo Cardaci, Salvatore Maugeri, Filippo Caraci · 2023 · Current Research in Pharmacology and Drug Discovery
  10. A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
    Sun, Yi, Xu, Lijuan, Zheng, Dongpeng, Wang, Jue, Liu, Guodong, Mo, Zixin, Liu, Chao, Zhang, Wannian, Yu, Jianqiang, Xing, Chengguo et al. · 2023 · Redox Biology
  11. Potential therapeutic use of plant flavonoids in AD and PD
    Sun Meng-zhen, Li Ju, Lanchun Zhang, Ding Cai-feng, Yang Shu-da, Yu Hao-fei, Hu Wei-yan · 2022 · Heliyon
  12. Vitamin C supplementation for diabetes management: A comprehensive narrative review
    Mason, Shaun A., Parker, Lewan, van der Pligt, Paige, Wadley, Glenn D. · 2023 · Free Radical Biology and Medicine
  13. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks
    Jogender Mehla, Itender Singh, Deepti Diwan, James W. Nelson, Molly Lawrence, Eunjae Lee, Adam Q. Bauer, David M. Holtzman, Gregory Joseph Zipfel · 2021 · Acta Neuropathologica Communications
  14. New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates
    Mohammad Eghtedari, Yaghoub Sarrafi, Hamid Nadri, Mohammad Reza Mahdavi, Alireza Moradi, Farshad Homayouni Moghadam, Saeed Emami, Loghman Firoozpour, Ali Asadipour, Omid Sabzevari et al. · 2017 · European Journal of Medicinal Chemistry
  15. Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease
    Gary Tin, Tarek Mohamed, Nyasha Gondora, Michael A. Beazely, Praveen P. N. Rao · 2015 · MedChemComm
  16. Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease
    Clayton A. Whitmore, Justin R. Haynes, William J. Behof, Adam J. Rosenberg, Mohammed Noor Tantawy, Brian C. Hachey, Brian E. Wadzinski, Benjamin W. Spiller, Todd E. Peterson, Krista C. Paffenroth et al. · 2022 · Pharmaceuticals
  17. Oxidation as an important factor of protein damage: Implications for Maillard reaction
    Lucie Trnková, Jakub Dršata, Iva Boušová · 2015 · Journal of Biosciences
  18. NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers
    Kiyoshi Fukuhara, Akiko Ohno, Yosuke Ota, Yuya Senoo, Keiko Maekawa, Haruhiro Okuda, Masaaki Kurihara, Alato Okuno, Shumpei Niida, Yoshiro Saito et al. · 2013 · Journal of Clinical Biochemistry and Nutrition
  19. Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease
    Ji‐Seon Seo, Kang-Woo Lee, Taekyung Kim, In‐Sun Baek, Joo‐Young Im, Pyung‐Lim Han · 2011 · Free Radical Biology and Medicine
  20. Oxidative Stress: A Putative Link Between Lower Urinary Tract Symptoms and Aging and Major Chronic Diseases
    Zhenqun Xu, Rania A. Elrashidy, Bo Li, Guiming Liu · 2022 · Frontiers in Medicine
  21. Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease
    Masaaki Akagi, Nobuaki Matsui, Haruka Akae, Nana Hirashima, Nobuyuki Fukuishi, Yoshiyasu Fukuyama, Reiko Akagi · 2015 · Journal of Pharmacological Sciences
  22. Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
    Md. Sahab Uddin, Md. Tanvir Kabir · 2019 · Springer eBooks
  23. Traditional Oriental Medicines and Alzheimer’s Disease
    Seong Gak Jeon, Eun Ji Song, Dongje Lee, Junyong Park, Yunkwon Nam, Jin-il Kim, Minho Moon · 2018 · Aging and Disease
  24. Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer's type
    Mohd Faraz Zafeer, Fakiha Firdaus, Ehraz Anis, Mohammad Salim Hossain · 2019 · NeuroToxicology
  25. Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice
    Emre Fertan, Kurt R. Stover, Michael G. Brant, Paul M. Stafford, Brendan Kelly, Elena Diez‐Cecilia, Aimée A. Wong, Donald Fredric Weaver, Richard E. Brown · 2019 · Frontiers in Pharmacology
  26. NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes
    Minna Oksanen, Ida Hyötyläinen, Kalevi Trontti, Taisia Rõlova, Sara Wojciechowski, Marja Koskuvi, Matti H. Viitanen, Anna–Liisa Levonen, Iiris Hovatta, Laurent Roybon et al. · 2019 · Glia
  27. The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer’s Disease
    Kimberly Barber, Patricia Mendonca, Karam F. A. Soliman · 2023 · Brain Sciences
  28. Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits
    Himanshu Kumar Bhakta, Chan Hum Park, Takako Yokozawa, Takashi Tanaka, Hyun Ah Jung, Jae Sue Choi · 2017 · Archives of Pharmacal Research
  29. Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
    Raghuraj Singh, Archna Panghal, Krishna Jadhav, Ashima Thakur, Rahul Kumar Verma, Charan Singh, Manoj Goyal, Jayant Kumar, Ajay Gajanan Namdeo · 2024 · Molecular Neurobiology
  30. Xanthone and Flavone Derivatives as Dual Agents with Acetylcholinesterase Inhibition and Antioxidant Activity as Potential Anti-Alzheimer Agents
    Inês Cruz, Ploenthip Puthongking, Sara M. M. Cravo, Andreia Palmeira, Honorina M. Cidade, Madalena M. M. Pinto, Emı́lia Sousa · 2017 · Journal of Chemistry
  31. The Role of Bioenergetics in Neurodegeneration
    Taylor A. Strope, Cole J. Birky, Heather Wilkins · 2022 · International Journal of Molecular Sciences
  32. The promising role of natural products in Alzheimer's disease
    Michelle Melgarejo da Rosa, Luciclaudio Cassimiro de Amorim, João Victor de Oliveira Alves, Irivânia Fidelis da Silva Aguiar, Fernanda Granja da Silva Oliveira, Márcia Vanusa da Silva, Maria Tereza Correia dos Santos · 2022 · Brain Disorders
  33. Serum Uric Acid Levels in Patients with Alzheimer's Disease: A Meta-Analysis
    Xueping Chen, Xiaoyan Guo, Rui Huang, Yongping Chen, Zhenzhen Zheng, Huifang Shang · 2014 · PLoS ONE
  34. Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
    Virginie Bottero, Judith A. Potashkin · 2019 · International Journal of Molecular Sciences
  35. Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model
    Eliezer Joseph, Daniel Miguel Ángel Villalobos-Acosta, Mónica Torres-Ramos, Eunice D. Farfán‐García, Modesto Gómez‐López, Ángel Miliar-García, Manuel Jonathan Fragoso-Vázquez, Iohanan Daniel García-Marín, José Correa‐Basurto, Martha Cecilia Rosales‐Hernández · 2019 · Journal of Molecular Neuroscience
  36. RETRACTED ARTICLE: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
    Panchanan Maiti, Zackary Bowers, Ali Bourcier, Jarod Morse, Gary Leo Dunbar · 2021 · Alzheimer s Research & Therapy · Retracted
  37. Misfolded protein oligomers induce an increase of intracellular Ca2+ causing an escalation of reactive oxidative species
    Giulia Fani, Chiara Ester La Torre, Roberta Cascella, Cristina Cecchi, Michele Vendruscolo, Fabrizio Chiti · 2022 · Cellular and Molecular Life Sciences
  38. Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
    Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, Marianesan Arockia Babu, Danish Iqbal, Abdulmajeed G. Almutary, Mosleh Mohammad Abomughaid, Mehnaz Kamal, Ana Cláudia Paiva‐Santos, Mohammed Alsaweed et al. · 2024 · Biomedicine & Pharmacotherapy
  39. Brain Endothelial Erythrophagocytosis and Hemoglobin Transmigration Across Brain Endothelium: Implications for Pathogenesis of Cerebral Microbleeds
    Rudy Chang, Juan Castillo, Alexander C. Zambon, Tatiana B. Krasieva, Mark Fisher, Rachita K. Sumbria · 2018 · Frontiers in Cellular Neuroscience
  40. Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K/Akt signaling pathway in parkinsonian cell model
    Yingqian Zhao, Qiang Wang, Yuan Wang, Jie Li, Gang Lu, Zhibin Liu · 2019 · Environmental Health and Preventive Medicine
  41. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin‐3‐carboxamide‐N‐morpholine Hybrids as New Anti‐Alzheimer Agents
    Maliheh Barazandeh Tehrani, Zahra Rezaei, Mehdi Asadi, Hossein Behnammanesh, Hamid Nadri, Fatemeh Afsharirad, Alireza Moradi, Bagher A. Larijani, Maryam Mohammadi‐Khanaposhtani, Mohammad Reza Mahdavi · 2019 · Chemistry & Biodiversity
  42. Changes in anticholinesterase, antioxidant activities and related bioactive compounds of carob pulp (Ceratonia siliqua L.) during ripening stages
    Fairouz Saci, Mostapha Bachir‐bey, Hayette Louailèche, Lynda Gali, Chawki Bensouıcı · 2019 · Journal of Food Measurement & Characterization
  43. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer’s disease
    Yash Pal Singh, Gauri Shankar, Shagufta Jahan, Gourav Singh, Navneet Kumar, Atanu Barik, Prabhat Upadhyay, Lovejit Singh, Kajal Kamble, Gireesh Kumar Singh et al. · 2021 · Bioorganic & Medicinal Chemistry
  44. Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
    A. S. Correia, N. Vale · 2021 · Pharmaceuticals
  45. Metal Chelators Coupled with Nanoparticles as Potential Therapeutic Agents for Alzheimer's Disease
    Gang Liu, Ping Men, George L. Perry, Mark A. Smith · 2009 · Journal of Nanoneuroscience
  46. Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer’s and Parkinson’s Disease and the Efficacy of Antioxidant Treatment
    Talin Gogna, Benjamin E. Housden, Annwyne Houldsworth · 2024 · Antioxidants
  47. Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
    Syed Haris Omar · 2017 · Biomedicine & Pharmacotherapy
  48. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice
    Eun-Jeong Yang, Usman Mahmood, Hyun-Ju Kim, Moonseok Choi, Yunjung Choi, Jean‐Pyo Lee, Joo‐Youn Cho, Jin Won Hyun, Yong Sik Kim, Moon‐Jeong Chang et al. · 2018 · Free Radical Biology and Medicine
  49. Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
    Adalier, Nur, Parker, Heath · 2016 · Antioxidants
  50. Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
    Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, Zhang Li · 2023 · International Journal of Molecular Sciences
  51. Lactuca capensis reverses memory deficits in Aβ1‐42‐induced an animal model of Alzheimer's disease
    Paula Alexandra Postu, Jaurès A. K. Noumedem, Oana Cioancă, Monica Hăncianu, Marius Mihăşan, Mitică Ciorpac, Lucian Gorgan, Brîndușa Alina Petre, Lucian Hriţcu · 2017 · Journal of Cellular and Molecular Medicine
  52. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
    Carlo Cervellati, Arianna Romani, Carlo M. Bergamini, Cristina Bosi, Juana María Sanz, Angelina Passaro, Giovanni Zuliani · 2014 · Clinical Chemistry and Laboratory Medicine (CCLM)
  53. Accelerated aging in major depression: the role of nitro-oxidative stress
    Luca, Maria, Luca, Antonina, Calandra, Carmela · 2013 · Oxidative Medicine and Cellular Longevity
  54. Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity
    Yalcin, Ayfer, Soddu, Elena, Turunc Bayrakdar, Ezgi, Uyanikgil, Yigit, Kanit, Lutfiye, Armagan, Guliz, Rassu, Giovanna, Gavini, Elisabetta, Giunchedi, Paolo · 2016 · Journal of Pharmaceutical Sciences
  55. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget‐Directed Ligands for the Treatment of Alzheimer's Disease
    Ondřej Benek, Ondřej Soukup, Markéta Benková, Lukáš Hroch, Vendula Šepsová, Petr Jošt, Martina Hrabinová, Daniel Jun, Kamil Kuča, Dominykas Zala et al. · 2015 · ChemMedChem
  56. Donepezil: A review of the recent structural modifications and their impact on anti-Alzheimer activity
    Noor ul Amin Mohsin, Matloob Ahmad · 2020 · Brazilian Journal of Pharmaceutical Sciences
  57. Disulfide-Rich Cyclic Peptides from Clitoria ternatea Protect against β-Amyloid Toxicity and Oxidative Stress in Transgenic Caenorhabditis elegans
    Neha V. Kalmankar, Hrudya Hari, Ramanathan Sowdhamini, Radhika Venkatesan · 2021 · Journal of Medicinal Chemistry
  58. Thiol metabolomics of endothelial cells using capillary liquid chromatography mass spectrometry with isotope coded affinity tags
    Wei Yuan, James L. Edwards · 2011 · Journal of Chromatography A
  59. Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease.
    Ameneh Moslemnezhad, Soleiman Mahjoub, Mehdi Moghadasi · 2016 · Europe PMC (PubMed Central)
  60. Emerging Roles of Sirtuin 6 in Alzheimer’s Disease
    Nurul Fatihah Mohamad Nasir, Azalina Zainuddin, Shaharum Shamsuddin · 2017 · Journal of Molecular Neuroscience
  61. Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer’s Disease: A Review of Recent Evidence from Mechanistic Studies
    Giasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez, Khalid M. Khan · 2025 · Journal of Xenobiotics
  62. H2O2 and PAF mediate Aβ1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761
    Chun Shi, Fengming Wu, Jie Xu · 2010 · Neurochemistry International
  63. Possible neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction
    Anil Kumar, Archi Aggrawal, Raghavender Pottabathini, Arti Singh · 2016 · Pharmacological Reports
  64. Therapeutic Potential of Extracellular Vesicles in Aging and Age-Related Diseases
    Jorge Sanz‐Ros, Cristina Mas‐Bargues, Nekane Romero-García, Javier Huete-Acevedo, Mar Dromant, Consuelo Borrás · 2022 · International Journal of Molecular Sciences
  65. Nontoxic and Neuroprotective β-Naphthotacrines for Alzheimer’s Disease
    Mario Esquivias-Pérez, Emna Maalej, Alejandro Romero, Fakher Chabchoub, Abdelouahid Samadi, Jose Luis Marco, María Jesús Oset‐Gasque · 2013 · Chemical Research in Toxicology
  66. Dual/Multitargeted Xanthone Derivatives for Alzheimer'S Disease: Where Do We Stand?
    Maria I Cruz, Honorina M. Cidade, Madalena M. M. Pinto · 2017 · Future Medicinal Chemistry
  67. 11β-HSD1 Inhibition by RL-118 Promotes Autophagy and Correlates with Reduced Oxidative Stress and Inflammation, Enhancing Cognitive Performance in SAMP8 Mouse Model
    Dolors Puigoriol‐Illamola, Christian Griñán‐Ferré, Foteini Vasilopoulou, Rosana Leiva, Santiago Vázquez, Mercè Pallàs · 2018 · Molecular Neurobiology
  68. Neurodegenerative Memory Disorders: A potential Role of Environmental Toxins
    Allison Caban‐Holt, Michelle Mattingly, Gregory E. Cooper, Frederick A. Schmitt · 2005 · Neurologic Clinics
  69. The phosphodiesterase 5 inhibitor, KJH‐1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage
    Lijun Zhang, Jae Hong Seo, Huan Li, Ghilsoo Nam, Hyun Ok Yang · 2018 · British Journal of Pharmacology
  70. The Influence of Serum Uric Acid Level on Alzheimer’s Disease: A Narrative Review
    Mengyuan Qiao, Chongli Chen, Yuqing Liang, Yuxi Luo, Wenbin Wu · 2021 · BioMed Research International
  71. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
    Ravinder Kumar Kaundal, Ashok Kumar Datusalia, Shyam Sundar Sharma · 2021 · Pharmacological Research
  72. α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease
    P. Yamini, R. S. Ray, Sonal Yadav, Jatinder Dhaliwal, Manisha Yadav, Kanthi Kiran Kondepudi, Kanwaljit Chopra · 2022 · Pharmacology Biochemistry and Behavior
  73. Cerebral organoids with chromosome 21 trisomy secrete Alzheimer’s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy
    Fertan, Emre, Böken, Dorothea, Murray, Aoife, Danial, John S. H., Lam, Jeff Y. L., Wu, Yunzhao, Goh, Pollyanna A., Alić, Ivan, Cheetham, Matthew R., Lobanova, Evgeniia et al. · 2024 · Molecular Psychiatry
  74. Prospective atom-based 3D-QSAR model prediction, pharmacophore generation, and molecular docking study of carbamate derivatives as dual inhibitors of AChE and MAO-B for Alzheimer’s disease
    Vikas Kumar, Nidhi Chadha, Anjani K. Tiwari, Neeta Sehgal, Anil Kumar Mishra · 2013 · Medicinal Chemistry Research
  75. Postprandial Hyperglycemia Is Associated With White Matter Hyperintensity and Brain Atrophy in Older Patients With Type 2 Diabetes Mellitus
    Noriko Ogama, Takashi Sakurai, Shuji Kawashima, Takahisa Tanikawa, Haruhiko Tokuda, Shosuke Satake, Hisayuki Miura, Atsuya Shimizu, Manabu Kokubo, Shumpei Niida et al. · 2018 · Frontiers in Aging Neuroscience
  76. GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
    Magdalena Złotek, Antonina Kurowska, Mariola Herbet, Iwona Piątkowska‐Chmiel · 2023 · Biomedicines
  77. Proteomics analysis identifies PARK7 as an important player for renal cell resistance and survival under oxidative stress
    Marwa Eltoweissy, Gerhard Anton Muller, Asima Bibi, Phuc Van Nguye, Gry Helene Dihazi, Claudia A. Müller, Hassan Dihazi · 2011 · Molecular BioSystems
  78. Garcinol promotes Neurogenesis in Rat Cortical Progenitor Cells through the Duration of Extracellular Signal-Regulated Kinase Signaling
    Meng‐Shih Weng, Chiung‐Ho Liao, Sheng-Yung Yu, Jen‐Kun Lin · 2011 · Journal of Agricultural and Food Chemistry
  79. Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors
    Ornella Di Pietro, Nelson Alencar, Gerard Esteban, Elisabet Viayna, Natalia Szałaj, Javier Vázquez, Jordi Juárez‐Jiménez, Irene Sola, Belén Pérez, Montse Solé et al. · 2016 · Bioorganic & Medicinal Chemistry
  80. Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
    Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, Michele Siqueira, Anne Caroline Marcos, Marialice Heider, Caroline Soares Motta, Silvia Torices, Michal J. Toborek, Joice Stipursky · 2022 · Fluids and Barriers of the CNS
  81. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
    Rose Chesworth, David Cheng, Chloe Staub, Tim Karl · 2022 · Frontiers in Pharmacology
  82. In Vitro and In Vivo Neuroprotective Effects of Sarcosine
    Arzugül Tanas, Özlem Özdemir Tozlu, Tuğba Gezmiş, Ahmet Hacımüftüoğlu, A.M. Abd El‐Aty, Onur Ceylan, Adil Mardinoğlu, Hasan Türkez · 2022 · BioMed Research International
  83. Increased hippocampal quinone reductase 2 in Alzheimer's disease
    Tetsuya Hashimoto, Masami Nakai · 2011 · Neuroscience Letters
  84. Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against Oxidative Stress in Alzheimer Disease
    Nasreena Sajjad, Abubakar Wani, Ankita Sharma, Rohaya Ali, Sumaya Hassan, Rabia Hamid, Huma Habib, Bashir Ahmad Ganai · 2019 · Cellular and Molecular Neurobiology
  85. Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β.
    Liqin Qi, Z Chen, Yuhan Wang, Xiaoying Liu, Xiaohong Liu, Linfang Ke, Zhongjie Zheng, Xiaowei Lin, Yu Zhou, L Liu et al. · 2017 · Europe PMC (PubMed Central)
  86. Reactive X (where X = O, N, S, C, Cl, Br, and I) species nanomedicine
    Keyi Wang, Weipu Mao, Xinran Song, Ming Chen, Wei Feng, Bo Peng, Yu Chen · 2023 · Chemical Society Reviews
  87. Alzheimer's Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by Combined Vitamin D and l -Cysteine Supplementation
    Sushil Kumar Jain, Christopher M. Stevens, Jeffrey Justin Margret, Steven N. Levine · 2023 · Antioxidants and Redox Signaling
  88. Cholinesterase inhibitory activity, antioxidant properties, and phytochemical composition ofChlorococcumsp. extracts
    Tosin Abiola Olasehinde, Ademola Olufolahan Olaniran, Anthony Ifeanyi Okoh · 2020 · Journal of Food Biochemistry
  89. Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?
    Juan Tortosa‐Martínez, Angela Clow · 2012 · Stress
  90. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
    Rohit Pardeshi, Nityanand B. Bolshette, Kundlik Gadhave, Mohammad Arfeen, Sahabuddin Ahmed, Rohitash Jamwal, Bruce D. Hammock, Mangala Lahkar, Sumanta Kumar Goswami · 2019 · Frontiers in Pharmacology
  91. Intermittent theta burst stimulation attenuates oxidative stress and reactive astrogliosis in the streptozotocin-induced model of Alzheimer’s disease-like pathology
    Jelena Stanojevic, Milica Zeljković, Milorad Dragić, Ivana R. Stojanović, Tihomir V Ilic, Ivana D. Stevanović, Milica Ninković · 2023 · Frontiers in Aging Neuroscience
  92. Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer's disease: Relevance to its anti-inflammatory and antioxidant effects
    Amin Iranpanah, Sajad Fakhri, Gholamreza Bahrami, Mohammad Bagher Majnooni, Mohammad Mehdi Gravandi, Sara Taghavi, Mehdi Azadi Badrbani, Roshanak Amirian, Mohammad Hosein Farzaei · 2024 · Journal of Ethnopharmacology
  93. Immunohistochemical study of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 in the hippocampal vasculature: Pathological synergy of Alzheimer's disease and diabetes mellitus
    Tony Valente, Alejandro Gella, Montse Solé, Núria Durany, Mercedes Unzeta · 2012 · Journal of Neuroscience Research
  94. Analyzing Nootropic Effect of Phyllanthus reticulatus Poir. on Cognitive Functions, Brain Antioxidant Enzymes and Acetylcholinesterase Activity against Aluminium-Induced Alzheimer’s Model in Rats: Applicable for Controlling the Risk Factors of Alzheimer’s Disease
    Md. Sahab Uddin, Abdullah Al Mamun, Mohammed Ashraful Iqbal, Ariful Islam, Md. Farhad Hossain, Sayema Khanum, Mamunur Rashid · 2016 · Advances in Alzheimer s Disease
  95. RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
    Sanjay Awasthi, Ashly Hindle, Neha A. Sawant, Mathew George, Murali Vijayan, Sudhir Kshirsagar, Hallie Morton, Lloyd E. Bunquin, Philip Palade, J. Josh Lawrence et al. · 2021 · Cells
  96. Oxidation, Glycation, and Carbamylation of Salivary Biomolecules in Healthy Children, Adults, and the Elderly: Can Saliva Be Used in the Assessment of Aging?
    Mateusz Maciejczyk, Miłosz Nesterowicz, Julita Szulimowska, Anna Zalewska · 2022 · Journal of Inflammation Research
  97. From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis
    Tyler J. Margetts, Hannah S. Wang, Sonali Jayant Karnik, Lilian Irene Plotkin, Alexandru Movilă, Adrian L. Oblak, Jill C. Fehrenbacher, Melissa A. Kacena · 2024 · Current Osteoporosis Reports
  98. Advanced Glycation End Products-Induced Alzheimer’s Disease and Its Novel Therapeutic Approaches: A Comprehensive Review
    Dhivya Kothandan, Daniel S Singh, Goutham Yerrakula, D. Backkiyashree, Pratibha N, Vincy Santhana Sophia B, A Ramya, Sapthami Ramya VG, S Keshavini, M Jagadheeshwari · 2024 · Cureus
  99. Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer’s Disease
    Sakae Yumoto, Shigeo Kakimi, Akira Ishikawa · 2018 · Journal of Alzheimer s Disease
  100. Polyamine-Derived Aminoaldehydes and Acrolein: Cytotoxicity, Reactivity and Analysis of the Induced Protein Modifications
    Marek Šebela, Michaela Rašková · 2023 · Molecules